Skip to main content

Table 1 General characteristics of the adult study population (n = 1463) according to the outcome at 12 months after starting combination antiretroviral therapy

From: Improved antiretroviral treatment outcome in a rural African setting is associated with cART initiation at higher CD4 cell counts and better general health condition

Characteristics at 12 months All patients N = 1463 Death or lost to follow-up N = 318 Alive and on cART N = 1145 p-value dead vs. alive
   n % n % n %  
Median age, IQR 40 34-47 40 33-48 40 34-47 0.913
Males   518 35.4 130 40.9 388 33.9 0.021
Marital status Single 213 14.6 24 7.6 189 16.5 <0.001
  Married 390 26.7 48 15.1 342 29.9  
  Divorced or Widowed 277 18.9 37 11.6 240 21.0  
  No information 583 39.8 209 65.7 374 32.7  
Median weight, IQR 50 43-56 45 39-52 51 44-57 <0.001
Median hemoglobin, IQR 9.5 8-11 8.8 7.4-10.7 9.8 8.2-11.1 <0.001
WHO stage I 162 11.1 11 3.5 151 13.2 <0.001
  II 155 10.6 7 2.2 148 12.9  
  III 279 19.0 31 9.8 248 21.7  
  IV 197 13.5 40 12.6 157 13.7  
  No information 670 45.8 229 72.0 441 38.5  
Median CD4 cell count, IQR 131 54-234 80 27-156 130 60-205 <0.001
Tuberculosis Proven 111 7.6 19 6.0 92 8.0 <0.001
  Suspected 538 36.8 62 19.5 476 41.6  
cART Nevirapine-based 890 60.8 130 40.9 760 66.4 <0.001
  Efavirenz-based 162 11.1 23 7.2 139 12.1  
  No information 411 28.1 165 51.9 246 21.5  
Distance to clinic <10 km 710 48.5 143 45.0 567 49.5 0.561
  10-50 km 271 18.5 66 20.7 205 17.9  
  50-100 km 276 18.9 59 18.5 217 19.0  
  >100 km 134 9.2 33 10.4 101 8.8  
  No information 72 4.9 17 5.4 55 4.8